Bionano Genomics, Inc.
BNGO
$1.18
-$0.02-1.67%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 56.73% | 62.25% | 76.44% | 71.58% | 63.58% |
| Total Depreciation and Amortization | -27.00% | -29.63% | -31.60% | -36.51% | -2.79% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -86.36% | -81.14% | -100.79% | -75.69% | -65.74% |
| Change in Net Operating Assets | -145.38% | -342.95% | -87.64% | 155.23% | 205.76% |
| Cash from Operations | 21.42% | 55.70% | 76.28% | 79.75% | 75.22% |
| Capital Expenditure | -- | -- | -- | 100.00% | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 227.74% | -44.75% | -117.24% | -184.32% | -126.21% |
| Cash from Investing | 227.74% | -44.40% | -117.26% | -188.95% | -126.65% |
| Total Debt Issued | -- | -- | -- | -100.00% | -100.00% |
| Total Debt Repaid | -84.60% | 88.83% | 92.51% | 90.50% | 90.74% |
| Issuance of Common Stock | -51.84% | -56.33% | -30.01% | -26.41% | -35.86% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 73.56% | 88.40% | 78.94% | 87.81% | 79.10% |
| Cash from Financing | -88.13% | -26.66% | 275.66% | -48.29% | -61.25% |
| Foreign Exchange rate Adjustments | 315.38% | -70.00% | -57.14% | -148.89% | -218.18% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 103.66% | 110.27% | 42.29% | 76.22% | -377.80% |